Role of the B‐cell response in recovery of mice from primary influenza virus infection
暂无分享,去创建一个
[1] K. Mozdzanowska,et al. A pulmonary influenza virus infection in SCID mice can be cured by treatment with hemagglutinin-specific antibodies that display very low virus-neutralizing activity in vitro , 1997, Journal of virology.
[2] R. Zinkernagel,et al. Protection against immunopathological consequences of a viral infection by activated but not resting cytotoxic T cells: T cell memory without "memory T cells"? , 1997, Proceedings of the National Academy of Sciences of the United States of America.
[3] R. Zinkernagel,et al. The role of somatic mutation in the generation of the protective humoral immune response against vesicular stomatitis virus. , 1996, Immunity.
[4] A. Kelso,et al. Functionally distinct T cells in three compartments of the respiratory tract after influenza virus infection , 1996, European journal of immunology.
[5] D. Ernst,et al. CD4+ T cell activation and tolerance induction in B cell knockout mice , 1996, The Journal of experimental medicine.
[6] P. Doherty,et al. Immune CD4+ T cells promote the clearance of influenza virus from major histocompatibility complex class II -/- respiratory epithelium , 1996, Journal of virology.
[7] W. Liles,et al. Review: nomenclature and biologic significance of cytokines involved in inflammation and the host immune response. , 1995, The Journal of infectious diseases.
[8] J. West,et al. B lymphocytes can be competent antigen-presenting cells for priming CD4+ T cells to protein antigens in vivo. , 1995, Journal of immunology.
[9] A. Sher,et al. Successful T Cell Priming in B Cell-deficient Mice , 1995 .
[10] R. Webster,et al. The B-cell response in lymphoid tissue of mice immunized with various antigenic forms of the influenza virus hemagglutinin , 1995, Journal of virology.
[11] Y. Wu,et al. Gene-targeted B-deficient mice reveal a critical role for B cells in the CD4 T cell response. , 1995, International immunology.
[12] K. Mozdzanowska,et al. Virus-neutralizing antibodies of immunoglobulin G (IgG) but not of IgM or IgA isotypes can cure influenza virus pneumonia in SCID mice , 1995, Journal of virology.
[13] P. Doherty,et al. Clearance of Sendai virus by CD8+ T cells requires direct targeting to virus‐infected epithelium , 1995, European journal of immunology.
[14] M. Graham,et al. Influenza virus-specific CD4+ T helper type 2 T lymphocytes do not promote recovery from experimental virus infection , 1994, The Journal of experimental medicine.
[15] H. Klenk,et al. Cell tropism of influenza virus mediated by hemagglutinin activation at the stage of virus entry. , 1994, Virology.
[16] R. Coffman,et al. Administration of anti-IFN-gamma antibody to beta 2-microglobulin-deficient mice delays influenza virus clearance but does not switch the response to a T helper cell 2 phenotype. , 1994, Journal of immunology.
[17] R M Zinkernagel,et al. How many specific B cells are needed to protect against a virus? , 1994, Journal of immunology.
[18] M. Ogimoto,et al. Negative regulation of apoptotic death in immature B cells by CD45. , 1994, International immunology.
[19] K. Mozdzanowska,et al. Heterosubtypic immunity to influenza type A virus in mice. Effector mechanisms and their longevity. , 1994, Journal of immunology.
[20] F. Alt,et al. Immunoglobulin gene rearrangement in B cell deficient mice generated by targeted deletion of the JH locus. , 1993, International immunology.
[21] A. Ramsay,et al. A case for cytokines as effector molecules in the resolution of virus infection. , 1993, Immunology today.
[22] R. Zinkernagel,et al. T cell-dependent IFN-gamma exerts an antiviral effect in the central nervous system but not in peripheral solid organs. , 1993, Journal of immunology.
[23] W. Allan,et al. Activation of cytokine genes in T cells during primary and secondary murine influenza pneumonia , 1993, The Journal of experimental medicine.
[24] T. Croghan,et al. Transgenic mice lacking class I major histocompatibility complex- restricted T cells have delayed viral clearance and increased mortality after influenza virus challenge , 1992, The Journal of experimental medicine.
[25] P. Scherle,et al. Mice can recover from pulmonary influenza virus infection in the absence of class I-restricted cytotoxic T cells. , 1992, Journal of immunology.
[26] L. Staudt,et al. A B cell population that dominates the primary response to influenza virus hemagglutinin does not participate in the memory response , 1991, European journal of immunology.
[27] R. Jaenisch,et al. Clearance of influenza virus respiratory infection in mice lacking class I major histocompatibility complex-restricted CD8+ T cells , 1991, The Journal of experimental medicine.
[28] R. Webster,et al. Influenza virus RNA in the lung and lymphoid tissue of immunologically intact and CD4-depleted mice. , 1991, The Journal of general virology.
[29] Klaus Rajewsky,et al. A B cell-deficient mouse by targeted disruption of the membrane exon of the immunoglobulin μ chain gene , 1991, Nature.
[30] P. Small,et al. Immunoglobulin A mediation of murine nasal anti-influenza virus immunity , 1991, Journal of Virology.
[31] L. Staudt,et al. A set of closely related antibodies dominates the primary antibody response to the antigenic site CB of the A/PR/8/34 influenza virus hemagglutinin. , 1990, Journal of immunology.
[32] P. Doherty,et al. Cellular events in the lymph node and lung of mice with influenza. Consequences of depleting CD4+ T cells. , 1990, Journal of immunology.
[33] E. Paoletti,et al. Characterization and immunological properties of influenza A virus nucleoprotein (NP): cell-associated NP isolated from infected cells or viral NP expressed by vaccinia recombinant virus do not confer protection. , 1990, The Journal of general virology.
[34] B. Askonas,et al. Murine CD4+ T cell clones vary in function in vitro and in influenza infection in vivo , 1990, International immunology.
[35] R. Lamb,et al. Passively transferred monoclonal antibody to the M2 protein inhibits influenza A virus replication in mice , 1990, Journal of virology.
[36] B. Askonas,et al. Rapid recovery of lung histology correlates with clearance of influenza virus by specific CD8+ cytotoxic T cells. , 1989, Immunology.
[37] R. Ramphal,et al. Passive serum antibody causes temporary recovery from influenza virus infection of the nose, trachea and lung of nude mice. , 1988, Immunology.
[38] T. Kipps,et al. Importance of immunoglobulin isotype in therapy of experimental autoimmune encephalomyelitis with monoclonal anti-CD4 antibody. , 1987, Journal of immunology.
[39] H. Waldmann,et al. Do L3T4+ T cells act as effector cells in protection against influenza virus infection. , 1987, Immunology.
[40] R. Levy,et al. Importance of antibody isotype in monoclonal anti-idiotype therapy of a murine B cell lymphoma. A study of hybridoma class switch variants. , 1986, Journal of immunology.
[41] I. Bernstein,et al. Influence of antibody isotype on passive serotherapy of lymphoma. , 1985, Journal of immunology.
[42] R. Chanock,et al. Quantitative aspects of passive immunity to respiratory syncytial virus infection in infant cotton rats , 1985, Journal of virology.
[43] T. Braciale,et al. In vivo effector function of influenza virus-specific cytotoxic T lymphocyte clones is highly specific , 1984, The Journal of experimental medicine.
[44] Y. Zee,et al. Dynamics of B-lymphocytes in the lungs of mice exposed to aerosolized influenza virus , 1981, Infection and immunity.
[45] J. Yewdell,et al. Expression of influenza A virus internal antigens on the surface of infected P815 cells. , 1981, Journal of immunology.
[46] F. Ennis,et al. Recovery from a viral respiratory infection. I. Influenza pneumonia in normal and T-deficient mice. , 1981, Journal of immunology.
[47] C. Sweet,et al. Pathogenicity of influenza virus , 1980, Microbiological reviews.
[48] R. Webster,et al. Monoclonal antibodies to influenza matrix protein: detection of low levels of matrix protein on abortively infected cells. , 1980, The Journal of general virology.
[49] R. Ramphal,et al. Serum antibody prevents lethal murine influenza pneumonitis but not tracheitis , 1979, Infection and immunity.
[50] G. Ada,et al. Transfer of specific cytotoxic T lymphocytes protects mice inoculated with influenza virus , 1978, Nature.
[51] J. Schulman,et al. Effects of cell mediated immunity in influenza virus infection in mice. , 1977, Developments in biological standardization.
[52] J. Oxford,et al. Early presence of ribonucleoprotein antigen on surface of influenza virus-infected cells , 1977, Nature.
[53] T. Iwasaki,et al. Defense mechanisms against primary influenza virus infection in mice. I. The roles of interferon and neutralizing antibodies and thymus dependence of interferon and antibody production. , 1977, Journal of immunology.
[54] J. Virelizier,et al. Host defenses against influenza virus: the role of anti-hemagglutinin antibody. , 1975, Journal of immunology.
[55] M. Eichelberger,et al. Roles of alpha beta and gamma delta T cell subsets in viral immunity. , 1992, Annual review of immunology.
[56] B. Murphy,et al. The systemic and mucosal immune response of humans to influenza A virus. , 1989, Current topics in microbiology and immunology.
[57] P. Brandtzaeg. Overview of the mucosal immune system. , 1989, Current topics in microbiology and immunology.
[58] G. Ada,et al. The immune response to influenza infection. , 1986, Current topics in microbiology and immunology.
[59] R B Couch,et al. Immunity to influenza in man. , 1983, Annual review of microbiology.
[60] A. Allison,et al. Immune responses to influenza virus in the mouse, and their role in control of the infection. , 1979, British medical bulletin.
[61] R M Zinkernagel,et al. MHC-restricted cytotoxic T cells: studies on the biological role of polymorphic major transplantation antigens determining T-cell restriction-specificity, function, and responsiveness. , 1979, Advances in immunology.
[62] Y. S. Shvartsman,et al. Secretory anti-influenza immunity. , 1976, Advances in immunology.
[63] H. B. Kaltreider. Expression of immune mechanisms in the lung. , 1976, The American review of respiratory disease.